Bridgewater Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.92M | Buy |
10,044
+17
| +0.2% | +$3.25K | 0.15% | 80 |
|
2025
Q1 | $1.94M | Buy |
+10,027
| New | +$1.94M | 0.17% | 75 |
|
2022
Q3 | – | Sell |
-3,011
| Closed | -$461K | – | 127 |
|
2022
Q2 | $461K | Sell |
3,011
-204
| -6% | -$31.2K | 0.1% | 143 |
|
2022
Q1 | $521K | Buy |
3,215
+675
| +27% | +$109K | 0.13% | 138 |
|
2021
Q4 | $344K | Buy |
2,540
+47
| +2% | +$6.37K | 0.08% | 177 |
|
2021
Q3 | $269K | Buy |
2,493
+102
| +4% | +$11K | 0.07% | 200 |
|
2021
Q2 | $269K | Buy |
+2,391
| New | +$269K | 0.09% | 195 |
|